174 related articles for article (PubMed ID: 36649244)
41. Effect of Toll-like receptor-2, -4, -5, -7, and NOD2 stimulation on potassium channel conductance in intestinal epithelial cells.
Cosme D; Soares-da-Silva P; Magro F
Am J Physiol Gastrointest Liver Physiol; 2022 Nov; 323(5):G410-G419. PubMed ID: 36040119
[TBL] [Abstract][Full Text] [Related]
42. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance of immunoscore related markers in bladder cancer.
Ariafar A; Sanati A; Ahmadvand S; Shekarkhar G; Safaei A; Shayan Z; Faghih Z
BMC Urol; 2022 Aug; 22(1):133. PubMed ID: 36038861
[TBL] [Abstract][Full Text] [Related]
44. Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells.
van Aubel RA; Keestra AM; Krooshoop DJ; van Eden W; van Putten JP
Mol Immunol; 2007 Jul; 44(15):3702-14. PubMed ID: 17493681
[TBL] [Abstract][Full Text] [Related]
45. Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer.
Lanki MA; Seppänen HE; Mustonen HK; Böckelman C; Juuti AT; Hagström JK; Haglund CH
Tumour Biol; 2018 Sep; 40(9):1010428318801188. PubMed ID: 30246618
[TBL] [Abstract][Full Text] [Related]
46. Leukocyte toll-like receptor expression in pathergy positive and negative Behçet's disease patients.
van der Houwen TB; Dik WA; Goeijenbier M; Hayat M; Nagtzaam NMA; van Hagen M; van Laar JAM
Rheumatology (Oxford); 2020 Dec; 59(12):3971-3979. PubMed ID: 32756992
[TBL] [Abstract][Full Text] [Related]
47. [Immune-Related Factors as Prognostic Markers for Resectable Colorectal Cancer].
Tomochika S; Kuwahara T; Suzuki N; Hazama S; Nagano H
Gan To Kagaku Ryoho; 2021 Mar; 48(3):325-330. PubMed ID: 33790150
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of TLRs and IL-6 as a marker in human colorectal cancer.
Lu CC; Kuo HC; Wang FS; Jou MH; Lee KC; Chuang JH
Int J Mol Sci; 2014 Dec; 16(1):159-77. PubMed ID: 25547486
[TBL] [Abstract][Full Text] [Related]
49. Toll-like receptors TLR-2, TLR-4, TLR-7, and TLR-9 in tumor tissue and serum of the patients with esophageal squamous cell carcinoma and gastro-esophageal junction cancer.
Diakowska D; Nienartowicz M; Grabowski K; Rosińczuk J; Krzystek-Korpacka M
Adv Clin Exp Med; 2019 Apr; 28(4):515-522. PubMed ID: 29968427
[TBL] [Abstract][Full Text] [Related]
50. Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study.
Alwers E; Kather JN; Kloor M; Brobeil A; Tagscherer KE; Roth W; Echle A; Amitay EL; Chang-Claude J; Brenner H; Hoffmeister M
J Pathol Clin Res; 2023 Mar; 9(2):129-136. PubMed ID: 36424650
[TBL] [Abstract][Full Text] [Related]
51. Plasmatic membrane toll-like receptor expressions in human astrocytomas.
Moretti IF; Franco DG; de Almeida Galatro TF; Oba-Shinjo SM; Marie SKN
PLoS One; 2018; 13(6):e0199211. PubMed ID: 29912993
[TBL] [Abstract][Full Text] [Related]
52. The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma.
Kim Y; Wen X; Bae JM; Kim JH; Cho NY; Kang GH
Histopathology; 2018 Oct; 73(4):663-671. PubMed ID: 29906313
[TBL] [Abstract][Full Text] [Related]
53. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
[TBL] [Abstract][Full Text] [Related]
54. CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer Survival.
Satoyoshi T; Hirohashi Y; Okuya K; Miyo M; Akizuki E; Ishii M; Miura R; Kubo T; Murata K; Kanaseki T; Tsukahara T; Takemasa I; Torigoe T
Anticancer Res; 2024 Apr; 44(4):1603-1610. PubMed ID: 38537969
[TBL] [Abstract][Full Text] [Related]
55. Artificial intelligence-based analysis of tumor-infiltrating lymphocyte spatial distribution for colorectal cancer prognosis.
Cai M; Zhao K; Wu L; Huang Y; Zhao M; Hu Q; Chen Q; Yao S; Li Z; Fan X; Liu Z
Chin Med J (Engl); 2024 Feb; 137(4):421-430. PubMed ID: 38238158
[TBL] [Abstract][Full Text] [Related]
56. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.
de Lollo C; de Moraes Vasconcelos D; da Silva Oliveira LM; de Oliveira Titz T; Carneiro-Sampaio M; Jacob CM; da Silva Duarte AJ; Sato MN
J Transl Med; 2016 May; 14(1):138. PubMed ID: 27188997
[TBL] [Abstract][Full Text] [Related]
57. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract][Full Text] [Related]
58. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of tumor-infiltrating CD8⁺ or CD3⁺ T lymphocytes and interleukin-2 expression in radically resected non-small cell lung cancer.
Tian C; Lu S; Fan Q; Zhang W; Jiao S; Zhao X; Wu Z; Sun L; Wang L
Chin Med J (Engl); 2015 Jan; 128(1):105-10. PubMed ID: 25563322
[TBL] [Abstract][Full Text] [Related]
60. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis.
Mansson A; Adner M; Cardell LO
Respir Res; 2006 Feb; 7(1):36. PubMed ID: 16504163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
